Featured Entrepreneurs

Since 2010, MassChallenge has accelerated 2,458 startups that have raised more than $6.2 billion in funding, generated more than $3+ billion in revenue, and created more than 157,000 total jobs. 

Our startups

Be inspired. Search our startups.


Depression affects 350 Million world-wide every year. A third of patients do not respond to treatment and struggle to find an adequate solution for their depression. Genetika+ is developing the first cellular and genetic based platform to provide meaningful predictions of patient responses to antidepressants. This technology will allow patients to find their best treatment for depression more rapidly and accurately.
Genetika+ uses innovative personalized medicine tools to help depression sufferers find their best treatment, faster and more accurately.

Connect with Genetika+


2018 Diamond Israel

Sub industry


Additional Industries
Therapeutics (Pharma / Biotech)


MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.